Cargando…

Long term results of different radiotherapy techniques and fractions for esophageal squamous cell carcinoma

BACKGROUND: Radiotherapy plays an important role in multidisciplinary treatment of esophageal squamous cell carcinoma (ESCC). However, the long term prognosis, relapse and metastasis of patients who received radiotherapy with different radiotherapy technique and fractions were unclear. The objective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Jiaying, Xia, Yi, Chen, Yun, Liu, Qi, Chen, Weiwei, Zhao, Kuaile
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798345/ https://www.ncbi.nlm.nih.gov/pubmed/35117589 http://dx.doi.org/10.21037/tcr.2020.03.47

Ejemplares similares

The Prognosis and Feasibility of Extensive Clinical Target Volume in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial
por: Zhang, Xiaofei, et al.
Publicado: (2021)

A nomogram and risk classification model predicts prognosis in Chinese esophageal squamous cell carcinoma patients
por: Deng, Jiaying, et al.
Publicado: (2022)

A study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin for advanced esophageal squamous cell carcinoma with T4 and/or M1 lymph node metastasis or locoregional recurrence
por: Liu, Qi, et al.
Publicado: (2020)

Long-Term Results of a Phase 2 Study of Definitive Chemoradiation Therapy Using S-1 for Esophageal Squamous Cell Carcinoma Patients Who Were Elderly or With Serious Comorbidities
por: Chen, Yun, et al.
Publicado: (2022)

Identification of the Germline Mutation Profile in Esophageal Squamous Cell Carcinoma by Whole Exome Sequencing
por: Deng, Jiaying, et al.
Publicado: (2019)

Methylation and expression of PTPN22 in esophageal squamous cell carcinoma
por: Deng, Jiaying, et al.
Publicado: (2016)

Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma
por: Zhu, Han-Ting, et al.
Publicado: (2017)

Long-term outcome of definitive radiotherapy for cervical esophageal squamous cell carcinoma
por: Sakanaka, Katsuyuki, et al.
Publicado: (2018)

A Phase II Study of Apatinib in Patients with Chemotherapy‐Refractory Esophageal Squamous Cell Carcinoma (ESO‐Shanghai 11)
por: Chu, Li, et al.
Publicado: (2021)

Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)
por: Ai, Dashan, et al.
Publicado: (2023)

Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma
por: Deng, Jiaying, et al.
Publicado: (2014)

Long-term outcome of irradiation with or without chemotherapy for esophageal squamous cell carcinoma: a final report on a prospective trial
por: Liu, Mina, et al.
Publicado: (2012)

Delayed postoperative radiotherapy might improve the long-term prognosis of locally advanced esophageal squamous cell carcinoma
por: Lin, Ming-qiang, et al.
Publicado: (2020)

Evaluation of the value of ENI in radiotherapy for cervical and upper thoracic esophageal cancer: a retrospective analysis
por: Liu, Mina, et al.
Publicado: (2014)

Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs
por: Tseng, Ihsuan, et al.
Publicado: (2023)

Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma
por: Zhu, Zhengfei, et al.
Publicado: (2015)

Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations
por: Deng, Jiaying, et al.
Publicado: (2017)

CBX4 contributes to radioresistance by regulating autophagic activity in esophageal squamous cell carcinoma
por: Zhu, Hongcheng, et al.
Publicado: (2022)

Long-Term Treatment Outcomes of the Elder Patients with Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma with Definitive Chemoradiotherapy or Radiotherapy
por: Liu, Junqing, et al.
Publicado: (2022)

Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma
por: Ochi, Masanori, et al.
Publicado: (2020)

Risk Factors Associated with Esophageal Fistula after Radiotherapy for Esophageal Squamous Cell Carcinoma
por: Hu, Bing, et al.
Publicado: (2020)

Cancer of Pharyngoesophageal Junction: A Different Subtype From Hypopharyngeal and Cervical Esophageal Cancer?
por: Li, Xiaoyu, et al.
Publicado: (2021)

Prognostic value of an immunohistochemical signature in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy
por: Meng, Jin, et al.
Publicado: (2018)

Less Irradiation to Lymphocyte-Related Organs Reduced the Risk of G4 Lymphopenia in Esophageal Cancer: Re-Analysis of Prospective Trials
por: Tseng, Ihsuan, et al.
Publicado: (2023)

Dosimetric analysis and biological evaluation between proton radiotherapy and photon radiotherapy for the long target of total esophageal squamous cell carcinoma
por: Cui, Yongbin, et al.
Publicado: (2022)

Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma
por: Pao, Tzu-Hui, et al.
Publicado: (2021)

Definitive Simultaneous Integrated Boost Versus Conventional-Fractionated Intensity Modulated Radiotherapy for Patients With Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis
por: Li, Chen, et al.
Publicado: (2021)

Long-term results of intensity-modulated radiotherapy with three dose-fractionation regimens for localized prostate cancer
por: Takemoto, Shinya, et al.
Publicado: (2019)

Long Term Results of Single-Fraction Carbon-Ion Radiotherapy for Non-small Cell Lung Cancer
por: Ono, Takashi, et al.
Publicado: (2020)

Efficacy of intensity-modulated radiotherapy for resected thoracic esophageal squamous cell carcinoma
por: Zhang, Wencheng, et al.
Publicado: (2015)

Dose escalation based on (18)F-FDG PET/CT response in definitive chemoradiotherapy of locally advanced esophageal squamous cell carcinoma: a phase III, open-label, randomized, controlled trial (ESO-Shanghai 12)
por: Zhu, Hongcheng, et al.
Publicado: (2022)

Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in Taiwan
por: Hsu, Ming-Hung, et al.
Publicado: (2021)

Long-term results of an endoscopic screening program for superficial esophageal cancer in patients with head and neck squamous cell carcinoma
por: Nobre Moura, Renata, et al.
Publicado: (2022)

Long-term survival after pulmonary metastasectomy in patients with esophageal squamous cell carcinoma with lung metastasis
por: Lo, Chien-Ming, et al.
Publicado: (2022)

Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice
por: Li, Minghuan, et al.
Publicado: (2016)

Novel Photodynamic Therapy for Esophageal Squamous Cell Carcinoma following Radiotherapy
por: Yanagita, Takumi, et al.
Publicado: (2023)

Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma
por: An, Lingbo, et al.
Publicado: (2023)

Correlates of Long-Term Survival of Patients with pN+ Esophageal Squamous Cell Carcinoma after Esophagectomy
por: He, Ming, et al.
Publicado: (2021)

Comparison  of  efficacy, safety, and costs between neoadjuvant hypofractionated radiotherapy and conventionally fractionated radiotherapy for esophageal carcinoma
por: Lyu, Jiahua, et al.
Publicado: (2019)

High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy
por: Wang, Chunyu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3qmpjma0oafmh2fs3q9gq5ne37